These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2945684)

  • 41. [Chrysotherapy in rheumatoid polyarthritis].
    Suţeanu S; Moangă M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):107-12. PubMed ID: 6139855
    [No Abstract]   [Full Text] [Related]  

  • 42. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myopathy due to mercaptopropionyl glycine.
    Hales DS; Scott R; Lewi HJ
    Br Med J (Clin Res Ed); 1982 Oct; 285(6346):939. PubMed ID: 6811078
    [No Abstract]   [Full Text] [Related]  

  • 44. [Radiological lesions of the hands in rheumatoid arthritis with rheumatoid factors and antinuclear antibodies].
    Punzi L; di Maggio C; Mazzi A; Presacco D; Ruffatti A; Pellegrini A; Todesco S
    Rev Rhum Mal Osteoartic; 1987; 54(7-9):563-6. PubMed ID: 3499656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effectiveness and complications of chrysotherapy of rheumatoid arthritis].
    Erov NK
    Revmatologiia (Mosk); 1986; (1):11-4. PubMed ID: 2940663
    [No Abstract]   [Full Text] [Related]  

  • 46. Injectable gold dermatitis and proteinuria: retreatment with auranofin.
    Tosi S; Cagnoli M; Guidi G; Murelli M; Messina K; Colombo B
    Int J Clin Pharmacol Res; 1985; 5(4):265-8. PubMed ID: 2932399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antinuclear antibody: predictive of lymphocyte response in rheumatoid arthritis.
    Menard HA; Dion J; Richard C
    J Rheumatol; 1977; 4(1):21-6. PubMed ID: 301940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Heterogeneity of antinuclear antibodies (ANA), immunoglobulin- and complement levels in sera of patients with rheumatoid arthritis (RA) (author's transl)].
    Dreher R
    Immun Infekt; 1977 Feb; 5(1):11-22. PubMed ID: 321331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between antinuclear antibodies and differential cell counts in synovial fluid of patients with rheumatoid arthritis.
    Zimmermann-Górska I; Wiik A; Potocka-Michajluk U; Cygert K
    Arch Immunol Ther Exp (Warsz); 1991; 39(4):391-6. PubMed ID: 1821615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)].
    Dreher R; Helmke K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of rheumatoid arthritis with gold salts].
    Aranguena L; Hinojosa W; Chincaro C; Portugal J; Barrenechea O
    Rev Clin Esp; 1984 Jun 15-30; 173(5-6):305-8. PubMed ID: 6238373
    [No Abstract]   [Full Text] [Related]  

  • 52. Antiperinuclear factor isotypes in rheumatoid arthritis.
    Borg AA
    Clin Exp Rheumatol; 1995; 13(4):529-31. PubMed ID: 7586793
    [No Abstract]   [Full Text] [Related]  

  • 53. Severe hypersensitivity reaction to gold. Positive lymphocyte transformation test.
    Walzer RA; Feinstein R; Shapiro L; Einbinder J
    Arch Dermatol; 1972 Aug; 106(2):231-4. PubMed ID: 4261763
    [No Abstract]   [Full Text] [Related]  

  • 54. Serum immunoglobulin levels and tissue antibodies in psoriasis.
    Lin RY; Deng JS; Lu YC
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1978 Jun; 11(2):45-9. PubMed ID: 310380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies of antinuclear antibodies in rheumatoid arthritis.
    Garcia-de la Torre I; Miranda-Mendez L
    J Rheumatol; 1982; 9(4):603-6. PubMed ID: 6182293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dermatitis caused by gold salts].
    Minghetti G; Tosti A; Veronesi S; Rizzoli D; Ferri S
    G Ital Dermatol Venereol; 1986; 121(6):425-6. PubMed ID: 2951321
    [No Abstract]   [Full Text] [Related]  

  • 57. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
    Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
    Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxicity due to remission inducing drugs in RA.
    Barger BO; Acton RT; Koopman WJ; Alarcon GS
    J Rheumatol; 1987 Feb; 14(1):175-6. PubMed ID: 3572923
    [No Abstract]   [Full Text] [Related]  

  • 59. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
    Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A
    J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.